2020 Annual Meeting Scientific Program Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Stock and Other Travel, (OPTIONAL) Consulting or Advisory Patents, Royalties, Other Expert Other Name Employment Leadership Ownership Honoraria Speakers' Bureau Research Funding Accommodations, Uncompensated Role Intellectual Property Testimony Relationship Interests Expenses Relationships Howard A. Burris III HCA Healthcare / HCA Healthcare HCA Healthcare / AstraZeneca (Inst), Agios (Inst), Arch (Inst), Arvinas (Inst), Novartis Sarah Cannon / Sarah Cannon Sarah Cannon Boehringer Ingelheim AstraZeneca (Inst), BioAtla (Inst), (Inst), Bristol-Myers BioMed Valley Discoveries (Inst), Squibb (Inst), Celgene Boehringer Ingelheim (Inst), Bristol- (Inst), Eisai (Inst), FORMA Myers Squibb (Inst), Celgene (Inst), Therapeutics (Inst), Incyte CicloMed (Inst), CytomX Therapeutics (Inst), Janssen (Inst), (Inst), eFFECTOR Therapeutics MedImmune (Inst), (Inst), Gilead Sciences (Inst), Mersana (Inst), Novartis GlaxoSmithKline (Inst), Harpoon (Inst), Roche/Genentech Therapeutics (Inst), Immunocore (Inst), Tolero (Inst), Incyte (Inst), Janssen (Inst), Pharmaceuticals (Inst) Jiangsu Hengrui Medicine (Inst), Jounce Therapeutics (Inst), Kyocera (Inst), Lilly (Inst), Loxo (Inst), Macrogenics (Inst), MedImmune (Inst), Merck (Inst), Millennium (Inst), Moderna Therapeutics (Inst), Novartis (Inst), Revolution Medicines (Inst), Roche/Genentech (Inst), Seattle Genetics (Inst), Takeda (Inst), Tesaro (Inst), TG Therapeutics (Inst), Verastem (Inst), Vertex (Inst)
Suzanne George Abbott Laboratories, Bayer, Blueprint ARIAD (Inst), Bayer (Inst), Blueprint UptoDate Bayer Research to Abbvie (I), Allergan Medicines, Deciphera, Medicines (Inst), Deciphera (Inst), Practice (I) Lilly, MORE Health, Novartis (Inst), Pfizer (Inst) Research to Practice, UpToDate Norah L. Henry Abbvie (Inst), Innocrin Pharma (Inst), Pfizer (Inst) Melissa L. Johnson Araxes Pharma (Inst), Abbvie (Inst), Acerta Pharma (Inst), Abbvie, Astellas Astellas Pharma (I), Adaptimmune (Inst), Amgen (Inst), Pharma, AstraZeneca, AstraZeneca (Inst), Array BioPharma (Inst), AstraZeneca Boehringer Ingelheim, BeiGene (Inst), (Inst), BeiGene (Inst), BerGenBio Bristol-Myers Squibb, Boehringer Ingelheim (Inst), Birdie (Inst), Boehringer Clovis Oncology, Daiichi (Inst), Bristol-Myers Ingelheim (Inst), Bristol-Myers Squibb Sankyo, EMD Serono, Squibb (Inst), Calithera (Inst), Checkpoint Therapeutics (Inst), Exelixis, Genentech, Biosciences (Inst), Clovis Oncology (Inst), Corvus Incyte, Merck, Pfizer, Celgene (Inst), Pharmaceuticals (Inst), CytomX Sysmex, Vapotherm Genentech/Roche (Inst), Therapeutics (Inst), Daiichi Sankyo Guardant Health (Inst), (Inst), Dynavax (Inst), EMD Serono Incyte (Inst), Loxo (Inst), (Inst), Foundation Medicine (Inst), G1 Merck (Inst), Mersana Therapeutics (Inst), (Inst), Mirati Therapeutics Genentech/Roche (Inst), Genmab (Inst), Otsuka (I), Pfizer (Inst), Genocea Biosciences (Inst), (Inst), Ribon Therapeutics GlaxoSmithKline (Inst), Gritstone (Inst), Sanofi (Inst) Oncology (Inst), Guardant Health (Inst), Hengrui Pharmaceutical (Inst), Incyte (Inst), Janssen (Inst), Kadmon (Inst), Lilly (Inst), Loxo (Inst), Lycera (Inst), Merck (Inst), Mersana (Inst), Mirati Therapeutics (Inst), Neovia Oncology (Inst), Novartis (Inst), OncoMed (Inst), Pfizer (Inst), Regeneron (Inst), Sanofi (Inst), Shattuck Labs (Inst), Stem CentRx (Inst), Syndax (Inst), Takeda (Inst), Tarveda Therapeutics (Inst)
Biostatistics Karla V. Ballman Agenus, ARIAD, Prostate cancer signature Janssen Medtronic, Takeda patent (Inst), Immune Oncology, Lilly enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst)
Thomas Braun Johnson & OncoImmune Johnson (I) Suzanne E. AstraZeneca Patent pending for a Dahlberg statistical model assessing tumor growth (Inst)
Rosemarie Mick Editas Medicine Infiniti Medical Mary W. Redman Ignyta Yu Shyr Aduro Biotech, Royalty for TNBCType for GlaxoSmithKline, Janssen Insight Genetics. TNBCType Research & Development, is a web-based subtyping Novartis, Pfizer, tool TNBCtype for candidate Roche/Genentech TNBC samples using our gene expression meta data and classification method.
Nolan Wages Abbvie (Inst) Breast Cancer - Metastatic Adam Brufsky Agendia, Bayer, Bioarray Therapeutics, BioTheranostics, Celgene, Eisai, Genentech/Roche, Genomic Health, Lilly, Merck, Myriad Pharmaceuticals, NanoString Technologies, Novartis, Pfizer, Puma Biotechnology
Roisin M. Connolly Genentech/Roche (Inst), Macrogenics Genentech/Roche, (Inst), Merck (Inst), Merrimack (Inst), Syndax Novartis (Inst), Puma Biotechnology (Inst) Olwen M. Hahn Via Oncology Cardinal Health (I) Pfizer Cardinal Health (I) Erika P. Hamilton Boehringer Ingelheim Abbvie (Inst), Acerta Pharma (Inst), Amgen, AstraZeneca, (Inst), Cascadian ArQule (Inst), AstraZeneca (Inst), Bayer, Bristol-Myers Therapeutics (Inst), BerGenBio (Inst), Boehringer Squibb, Clovis Daiichi Sankyo (Inst), Ingelheim (Inst), Cascadian Oncology, Eisai, EMD Eisai (Inst), Therapeutics (Inst), Clovis Oncology Serono, Foundation Genentech/Roche (Inst), (Inst), Curis (Inst), CytomX Medicine, Genentech, Lilly (Inst), Mersana (Inst), Therapeutics (Inst), Daiichi Sankyo Genentech/Roche, Pfizer (Inst), Puma (Inst), Deciphera (Inst), eFFECTOR Genzyme, Guardant Biotechnology (Inst) Therapeutics (Inst), Eisai (Inst), EMD Health, Helsinn Serono (Inst), Fujifilm (Inst), Therapeutics, HERON, Genentech/Roche (Inst), H3 Lexicon, Lilly, Biomedicine (Inst), Hutchison Medivation, Merck, MediPharma (Inst), Immunomedics Novartis, Pfizer, Roche, (Inst), InventisBio (Inst), Kadmon Sysmex, Tesaro (Inst), Leap Therapeutics (Inst), Lilly (Inst), Lycera (Inst), Macrogenics (Inst), Mallinckrodt (Inst), MedImmune (Inst), Medivation (Inst), Mersana (Inst), Merus (Inst), Millennium (Inst), Novartis (Inst), Nucana (Inst), OncoMed (Inst), Oncothyreon (Inst), Pfizer (Inst), PharmaMar (Inst), Radius Health (Inst), Regeneron (Inst), Rgenix (Inst), Stem CentRx (Inst), Syndax (Inst), Syros Pharmaceuticals (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), TapImmune (Inst), Tesaro (Inst), TetraLogic Pharmaceuticals (Inst), Verastem (Inst), Zymeworks (Inst)
Elizabeth C. Reed Pfizer Pfizer/NCCN
Nicholas C. Turner AstraZeneca, Bicycle AstraZeneca (Inst), Bio-Rad (Inst), Therapeutics, Bristol- Clovis Oncology (Inst), Guardant Myers Squibb, Lilly, Merck Health (Inst), Pfizer (Inst), Roche Sharp & Dohme, Novartis, (Inst) Pfizer, Roche, Tesaro
Breast Cancer -Local/Regional/Adjuvant Lior Z. Braunstein Naamit K. Gerber OncLive Eun-Sil S. Hwang Henry M. Kuerer Cardinal Health, Genomic PER Genomic Health (Inst) NEJM Group, McGraw-Hill Health, Targeted Medical Publishing Education
Erica L. Mayer Context Therapeutics, Myriad Genetics (Inst), Pfizer (Inst) Eisai, Lilly, Novartis, Pfizer
Vered Stearns Iridium Therapeutics Abbvie, Biocept, MedImmune, Immunomedics Novartis, Pfizer, Puma Biotechnology
Richard C. Zellars
Cancer Prevention, Risk Reduction, and Genetics John R. Goffin Amgen, Boehringer AstraZeneca Ingelheim, Bristol-Myers Squibb, Merck Erin W. Hofstatter UpToDate Andrew McKenzie Mark E. Robson AstraZeneca AstraZeneca, McKesson Abbvie (Inst), AstraZeneca (Inst), AstraZeneca, Pfizer Clinical Care Daiichi Sankyo, Merck, InVitae (Inst), Medivation (Inst), Options, Physician Pfizer Myriad Genetics (Inst), Tesaro (Inst) Education Resource, Research to Practice
Nadine M. Tung AstraZeneca Care Delivery and Regulatory Policy Adam P. Dicker American Oncohost Apex, Celldex, Cybrexa Prostate Cancer Foundation We recently filed a patient: Wilson, Socini EMD Serono, Ferring, Dreamit Ventures Google Society for Therapeutics, EMD "doped beo compounds for Merck, Self Care Radiation Serono, Janssen, optically stimulated Catalyst Oncology, Johnson & Johnson, luminescence (OSL) and Department of Oncohost, Roche, Self thermoluminescence (TL) Defense- Care Catalyst, Thirdbridge radiation dosimetry" Prostate Cancer Research Program, NRG Oncology
Lynn J. Howie Ipsen National Breast Cancer Coalition Richard T. Lee Tracon (Inst) Grow Ohio Pharmaceuticals Enrique Soto Perez Roche (I) De Celis Ari Vanderwalde Bristol-Myers Squibb, Amgen (Inst), Merck (Inst), Genentech/Roche, Caris Genentech/Roche (Inst), Millennium Life Sciences, Compugen, (Inst), AstraZeneca (Inst), Polynoma Immunocore, Concerto (Inst), Lilly (Inst), Bristol-Myers Squibb Health-AI, Elsevier (Inst), Amgen (Inst), Replimune (Inst), Caris Life Sciences (Inst), EMD Serono (Inst)
Central Nervous System Tumors E. Antonio Chiocca DNAtrix Merck Advantagene, Alcyone Amgen Patents related to oncolytic Lifesciences, DNAtrix, virus technology, gene Insigthec, NanoTX, therapy, microRNA, Oncorus, Sigilon, exosome, antibodies StemGen, Tocagen, ZIOPHARM Oncology Timothy F. Notable Labs Abbvie, Agios, Alexion U.S. Provisional Application Global Coalition for Cloughesy Pharmaceuticals, Bayer, No.: 62/819,322 Adaptive Research Boehringer Ingelheim, Title: COMPOSITIONS AND 501(c)(3) Boston Biomedical, Bristol- METHODS FOR TREATING Myers Squibb, Celgene, CANCER Cortice, Deciphera, Filing Date: March 15, 2019 DelMar Pharmaceuticals, Inventor(s): David A. Genocea Biosciences, Nathanson et al. GW Pharmaceuticals, FH Reference No.: UCH- Human Longevity, Insys 17760 (32246-17760) Therapeutics, KIYATEC, Your Reference No.: [UCLA Lilly, Merck, NewGen 2019-630-1] US Therapeutics, Notable Labs, Novartis, Novocure, Novogen, Oxigene, Pfizer, Puma Biotechnology, Roche/Genentech, Sunovion, Tocagen, VBI Vaccines, VBL Therapeutics Wellcome Trust
Evanthia Galanis Abbvie (Inst), Celgene, Bristol-Myers Squibb (Inst), Genentech/Roche (Inst), Genentech/Roche (Inst), Merck (Inst), Oncorus TRACON Pharma (Inst) Monica Malik Developmental Therapeutics - Immunotherapy Julie R. Brahmer Amgen, Bristol-Myers AstraZeneca (Inst), Bristol-Myers Bristol-Myers Squibb, Bristol-Myers Squibb, Celgene, Squibb (Inst), Incyte (Inst), Janssen Merck Squibb, Merck Genentech, Janssen Oncology (Inst), Merck (Inst), Oncology, Lilly, Merck, Spectrum (Inst) Syndax Gerald S. Falchook HealthONE, EMD Serono, Fujifilm Total Health 3-V Biosciences (Inst), Abbvie (Inst), Handbook of Targeted Bristol-Myers Squibb, Sarah Cannon (Inst) Conferencing ADC Therapeutics (Inst), Aileron Cancer Therapy EMD Serono, Fujifilm, Research Therapeutics (Inst), Amgen (Inst), Millennium, Sarah Institute ARMO BioSciences (Inst), Cannon Research AstraZeneca (Inst), BeiGene (Inst), Institute Bioatla (Inst), Biothera (Inst), Celgene (Inst), Celldex (Inst), Ciclomed (Inst), Curegenix (Inst), Curis (Inst), Cyteir (Inst), DelMar Pharmaceuticals (Inst), eFFECTOR Therapeutics (Inst), EMD Serono (Inst), Exelixis (Inst), Fujifilm (Inst), Genmab (Inst), Hutchison MediPharma (Inst), Ignyta (Inst), Incyte (Inst), Jacobio (Inst), Jounce Therapeutics (Inst), Kolltan Pharmaceuticals (Inst), Lilly (Inst), Loxo (Inst), MedImmune (Inst), Merck (Inst), Millennium (Inst), miRNA Therapeutics (Inst), Novartis (Inst), OncoMed (Inst), Precision Oncology (Inst), Regeneron (Inst), Rgenix (Inst), Ribon Therapeutics (Inst), Strategia Therapeutics (Inst), Syndax (Inst), Taiho Pharmaceutical (Inst), Takeda (Inst), Tarveda Therapeutics (Inst), Tesaro (Inst), Tocagen (Inst), Turning Point (Inst), Vegenics (Inst), Xencor (Inst)
Jonathan W. Amgen, AstraZeneca, Merck Abbvie, Array BioPharma, Astellas Goldman Bristol-Myers Squibb, Pharma, Astex Pharmaceuticals, Celgene, Clovis AstraZeneca/MedImmune, Bristol- Oncology, Myers Squibb, Celgene, Clovis Genentech/Roche, Lilly, Oncology, Corvus Pharmaceuticals, Trovagene, Vortex Genentech/Roche, Lilly, Spectrum Biosciences Pharmaceuticals, Threshold Pharmaceuticals
James L. Gulley Astellas Medivation (Inst), Bavarian Nordic (Inst), Bristol-Myers Squibb (Inst), EMD Serono (Inst), Merck (Inst), NantBioScience (Inst), Pfizer (Inst) Ross L. Levine Qiagen Loxo, Imago, C4 Lily, Amgen Loxo, Imago, C4 Lilly, Amgen Celgene, Roche, Prelude C4 Therapeutics, Therapeutics, Therapeutics, Isoplexis, Therapeutics Qiagen, Genome, Isoplexis Celgene, Roche, Prelude Constellation, Incyte, Therapeutics Auron
Heather L. Amgen, AstraZeneca, Bristol-Myers Squibb (Inst), Lilly (Inst), Amgen, AstraZeneca, Genomic Health, McArthur Bristol-Myers Squibb, Merck (Inst), ZIOPHARM Oncology Bristol-Myers Squibb, Lilly Genentech, (Inst) Genentech, Immunomedics, Lilly, Immunomedics, Lilly, Merck, Pfizer, Spectrum Merck, Pfizer, Puma Pharmaceuticals Biotechnology, Spectrum Pharmaceuticals
Matthew I. Milowsky BioClin Therapeutics Acerta Pharma (Inst), Astellas Asieris Pharma (Inst), AstraZeneca (Inst), Boehringer Ingelheim (Inst), Bristol- Myers Squibb (Inst), Cerulean Pharma (Inst), Clovis Oncology (Inst), Constellation Pharmaceuticals (Inst), Innocrin Pharma (Inst), Inovio Pharmaceuticals (Inst), Jounce Therapeutics (Inst), MedImmune (Inst), Merck (Inst), Mirati Therapeutics (Inst), Roche/Genentech (Inst), Seattle Genetics (Inst), Syndax (Inst), X4 Pharmaceuticals (Inst)
Kurt A. Schalper Fluidigm, Merck, Abbvie, AstraZeneca/ Fluidigm, Merck Bristol-Myers Squibb, Eli Lilly, Merck, Takeda MedImmune, Celgene, Moderna Therapeutics, Navigate Pierre Fabre, Shattuck BioPharma, Onkaido Therapeutics, Labs Pierre Fabre, Surface Oncology, Takeda, Tesaro, Vasculox
Developmental Therapeutics - Molecularly Targeted Agents and Tumor Biology Joshi J. Alumkal Janssen Biotech Aragon Pharmaceuticals (Inst), Astellas Pharma (Inst), Gilead Sciences (Inst), Novartis (Inst), Zenith Epigenetics (Inst) Sunandana Array BioPharma, Array BioPharma, Bristol- Array BioPharma, Array BioPharma, Chandra Bristol Myers Myers Squibb, EMD Bristol-Myers Squibb, Bristol-Myers Squibb, EMD Serono, Regeneron Regeneron Squibb, EMD Serono, Regeneron Serono, Regeneron
Gregory M. Cote 2nd MD, Advance Agios (Inst), Bavarian Nordic, Boston Medical, Agios, Grand Biomedical (Inst), CBA (Inst), Eisai Rounds Health, (Inst), Epizyme (Inst), Macrogenics InfiniteMD, PharmaMar (Inst), Merck KGaA (Inst), PharmaMar (Inst), Plexxikon (Inst)
R D. Harvey Bristol-Myers Squibb, Abbvie (Inst), ArQule (Inst), GSK, Takeda AstraZeneca (Inst), Boston Biomedical (Inst), Calithera Biosciences (Inst), Celgene (Inst), Corvus Pharmaceuticals (Inst), Five Prime Therapeutics (Inst), Genmab (Inst), Halozyme (Inst), Incyte (Inst), Lilly (Inst), Meryx (Inst), Nektar (Inst), Pfizer (Inst), Rgenix (Inst), Tesaro (Inst), Xencor (Inst)
Meredith McKean Array BioPharma (Inst) Prelude Therapeutics (Inst), Genentech (Inst), Tizona Therapeutics (Inst), GlaxoSmithKline (Inst), IDEAYA Biosciences (Inst), Exelixis (Inst), Jacobio (Inst), Moderna Therapeutics (Inst), Regeneron (Inst)
Manish R. Patel Pfizer/EMD Serono, Celgene, Exelixis, Pharmacyclics/Janssen Genentech/Roche, Taiho Pharmaceutical Geoffrey Shapiro Almac Diagnostics, Astex Aileron Therapeutics (Inst), Array Patent #: 9872874, Title: Bayer, Bicycle Pharmaceuticals, Bayer, BioPharma (Inst), AstraZeneca (Inst), Dosage regimen for Therapeutics, G1 Bicycle Therapeutics, Bayer (Inst), CanBas (Inst), Cellceutix sapacitabine and seliciclib, Therapeutics, Lilly, Cybrexa Therapeutics, (Inst), Covidien (Inst), Curis (Inst), Issue Date: 1/23/2018; Pfizer, Sierra Oncology Daiichi Sankyo, Fusion Cyclacel (Inst), Genentech (Inst), Provisional Patent Pharmaceuticals, G1 GlaxoSmithKline (Inst), Immune #:62/538,319, Title: Therapeutics, Ipsen, Lilly, Design (Inst), Lilly (Inst), Merck (Inst), Compositions and methods Merck Serono, Pfizer, Merck Serono (Inst), Millennium (Inst), for predicting response and Roche, Sierra Oncology Mirati Therapeutics (Inst), Novartis resistance to CDK4/6 (Inst), Pfizer (Inst), PharmaMar (Inst), inhibition, Filed: 7/28/17 PTC Therapeutics (Inst), Puma Biotechnology (Inst), Roche (Inst), Sanofi (Inst), Seattle Genetics (Inst), Sierra Oncology (Inst), Syros (Inst), Tensha Therapeutics (Inst), Tesaro (Inst), Vertex (Inst)
Eddy S. Yang AstraZeneca, Strata Clovis Oncology (Inst), Lilly (Inst), Strata Oncology Oncology Novartis (Inst) Gastrointestinal Cancer - Colorectal and Anal Jordan Berlin Abbvie, Arno Bayer (Inst), BeiGene (Inst), Boston Abbvie, Bayer, Boston AstraZeneca Therapeutics, Biomedical (Inst), EMD Serono (Inst), Biomedical, EMD AstraZeneca, Bayer Genentech/Roche (Inst), Serono, Seattle Genetics Health, Celgene, Clovis, Immunomedics (Inst), Incyte (Inst), Cornerstone Karyopharm Therapeutics (Inst), Lilly Pharmaceuticals, Eisai, (Inst), Loxo (Inst), Macrogenics (Inst), EMD Serono, Five Prime Pfizer (Inst), Pharmacyclics (Inst), Therapeutics, Psioxus (Inst), Symphogen (Inst), Genentech/Roche, Ipsen, Taiho Pharmaceutical (Inst) lsk Biopharma, QED Therapeutics, Seattle Genetics
Andrea Cercek Bayer, Proteus Digital Abbvie, Bayer, Seattle Genetics Health James M. Cleary Bristol-Myers Squibb Merck, Tesaro Agios, Bristol-Myers Squibb, Roche Jennifer R. Eads Bristol-Myers Bristol-Myers Squibb Lexicon, Novartis AstraZeneca (Inst), Bayer (Inst), Bristol-Myers Squibb (I) Squibb (I) (I) Bristol-Myers Squibb (Inst), Calithera Biosciences (Inst), EMD Serono (Inst), HealthCare Pharmaceuticals (Inst), Merck (Inst), Symphony Evolution (Inst), Verastem (Inst)
Mark Kozloff Abbvie, Abbvie, Genentech/Roche Abbvie, Amgen, Genentech/Roche Boehringer Ingelheim, Celgene, Celgene, Genentech/Roche, Merck, Novartis, Rigel, Tesaro
Christopher H. Lieu Foundation Medicine, Merck Immune Design Ipsen Pharmaceuticals Fotios Loupakis Amgen, Bayer, Sanofi Amgen, Bayer, Roche, Amgen (Inst), Bayer (Inst), Merck Amgen, Merck Serono, Sanofi Serono (Inst), Roche (Inst) Roche Wen Wee Ma Athenex (Inst), Merrimack (Inst) Ritesh Rathore Prospect Medical AstraZeneca, Bristol- AstraZeneca, Bristol- Holdings Myers Squibb Myers Squibb
Hanna K. Sanoff Bayer (Inst) Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Steven Ades John A. Merck Serono, AstraZeneca, Basilea, Amgen, Bristol-Myers Amgen Bristol-Myers Squibb, Bridgewater SERVIER Bayer, Incyte, Merck Squibb, Celgene Bristol-Myers Squibb/ Serono, Roche, SERVIER Medarex, Merck Serono, MSD Oncology, SERVIER Sarah E. Hoffe Varian Medical IBA Varian Medical Varian Medical Systems (Inst) Varian Medical Systems Systems Systems Matthew H. Katz Abbvie, Alcresta Therapeutics Dan Laheru Colon GVAX Marcus S. Noel Celgene, Taiho Celgene, Taiho Pharmaceutical Pharmaceutical Manisha Palta Duke University Merck (Inst), Varian Medical Systems Up to Date- Annual royalties UpToDate (Inst) for being a section author
Bradley G. Somer Keith R. Unger Jiping Wang GenomiCare GenomiCare GenomiCare GenomiCare GenomiCare Judy S. Wang AstraZeneca/ MedImmune Genitourinary Cancer - Kidney and Bladder Karim Chamie AstraZeneca, Urogen Altor BioScience Pharma Toni K. Choueiri Dana Farber Dana Farber Alexion Alexion Pharmaceuticals, Agensys (Inst), Analysis Group (Inst), Medical writing and Cancer Hospital Cancer Hospital, Pharmaceuticals, Alligent, Analysis Group, AstraZeneca (Inst), Bayer (Inst), editorial assistance Kidney Cancer Alligent, Analysis ASCO, AstraZeneca, Bristol-Myers Squibb (Inst), Calithera support may have Association, Group, ASCO, Bayer, Bristol-Myers Biosciences (Inst), Celldex (Inst), been funded by NCCN AstraZeneca, Squibb, Cerulean Cerulean Pharma (Inst), Corvus Communications Bayer, Bristol-Myers Pharma, Clinical Care Pharmaceuticals (Inst), Eisai (Inst), companies funded Squibb, Cerulean Options, Corvus Exelixis (Inst), Foundation Medicine by pharmaceutical Pharma, Clinical Pharmaceuticals, Eisai, (Inst), GlaxoSmithKline (Inst), Ipsen companies such as Care Options, EMD Serono, Exelixis, (Inst), Merck (Inst), Novartis (Inst), ClinicalThinking, Corvus Foundation Medicine, Peloton Therapeutics (Inst), Pfizer Health Pharmaceuticals, GlaxoSmithKline, (Inst), Prometheus (Inst), Roche Interactions, Eisai, EMD Serono, Harborside Press, (Inst), Roche/Genentech (Inst), Envision Pharma Exelixis, Foundation HERON, Ipsen, Kidney Seattle Genetics/Astellas (Inst), Group, Fishawack Medicine, Cancer Journal, Lancet Takeda (Inst), TRACON Pharma Group of Genentech/Roche, Oncology, Lilly, Lpath, (Inst) Companies, GlaxoSmithKline, Merck, Michael J. Parexel Harborside Press, Hennessy Associates, HERON, Ipsen, Navinata Healthcare, Kidney Cancer NCCN, NEJM, Novartis, Journal, Lancet Platform Q, Peloton Oncology, Lilly, Therapeutics, Pfizer, Lpath, Merck, Prometheus Laboratories, Michael J. Roche/Genentech, Hennessy Sanofi/Aventis, UpToDate Associates, Navinata Healthcare, NCCN, NEJM, Novartis, Peloton Therapeutics, Pfizer, PlatformQ Health, Prometheus, Sanofi/Aventis, UpToDate Shilpa Gupta Nektar AstraZeneca, Exelixis, Genentech, Bristol-Myers Squibb, Astellas Medivation (Inst), Bristol- Janssen Oncology Janssen Oncology, Merck Janssen Oncology Myers Squibb (Inst), Incyte (Inst), MedImmune (Inst), Merck (Inst), Moderna Therapeutics (Inst), Pfizer (Inst) Rana R. McKay Astellas Medivation, Bayer (Inst), Pfizer (Inst) Bristol-Myers Squibb, Dendreon, Exelixis, Janssen, Novartis, Pfizer, Tempus Andrea Necchi Bayer (I) Bayer (I) AstraZeneca, AstraZeneca, Bayer, AstraZeneca (Inst), Merck Sharp & AstraZeneca, Janssen, Bayer (I) Foundation Bristol-Myers Squibb, Dohme (Inst) Merck Sharp & Dohme, Medicine, Janssen, Clovis Oncology, Incyte, Rainier Therapeutics, Merck, Roche Janssen, Merck Sharp & Roche Dohme, Rainier Therapeutics, Roche, Seattle Genetics/Astellas
Cristina Suarez Astellas Pharma, Bristol- AstraZeneca, Bristol- AB Science (Inst), Arog (Inst), Bristol-Myers Squibb, Rodriguez Myers Squibb, EUSA Myers Squibb, Ipsen, Astellas Pharma (Inst), AstraZeneca Roche Pharma, Ipsen, Novartis, Pfizer, (Inst), AVEO (Inst), Bayer (Inst), Pfizer, Sanofi Roche/Genentech Blueprint Medicines (Inst), Boehringer Ingelheim (Inst), Bristol-Myers Squibb (Inst), Calithera Biosciences (Inst), Clovis Oncology (Inst), Cougar Biotechnology (Inst), Deciphera (Inst), Exelixis (Inst), GlaxoSmithKline (Inst), Incyte (Inst), Janssen Oncology (Inst), Karyopharm Therapeutics (Inst), MedImmune (Inst), Millennium (Inst), Nanobiotix (Inst), Novartis (Inst), Pfizer (Inst), Puma Biotechnology (Inst), Roche/Genentech (Inst), SFJ Pharmaceuticals Group (Inst), Teva (Inst)
Genitourinary Cancer - Prostate, Testicular, and Penile William K. Kelly Conastellation Foundation Medicine, Bayer (Inst), Endocyte (Inst), Exelixis Janssen Oncology Pharma, Janssen Sanofi (Inst), Janssen Oncology (Inst), Oncology Novartis (Inst), Sanofi (Inst), Seattle Genetics (Inst) Colleen A. Lawton
Timur Mitin Oregon Health & UpToDate, Via Advance Medical Novocure UpToDate, chapter royalty Science Oncology University (OHSU) Eugene Shenderov LifeImmune Macrogenics (Inst) Patent pending in field of allergy immunology and blood diagnostics Mary-Ellen Taplin Amgen, Astellas AstraZeneca, Bayer, Best Bayer (Inst), Janssen-Ortho (Inst), Astellas Pharma, Bayer, Pharma, Doctors, Clovis Oncology, Medivation (Inst), Pfizer (Inst) Clovis Oncology, Incyte, AstraZeneca, Guidepoint Global, Incyte, Janssen Oncology, Bayer, Celegene, Janssen-Ortho, Myovant Medivation, Pfizer, Tokai Clovis Oncology, Sciences, Pfizer, Pharmaceuticals Guidepoint Global, Research to Practice, Incyte, Janssen- UpToDate Ortho, Pfizer, Progenics, Research to Practice, UpToDate
David R. Wise Best Doctors Foundation GLG, Guidepoint Global, Pfizer Medicine, OncLive Leap Therapeutics
Gynecologic Cancer Kevin V. AstraZeneca (Inst) Albuquerque Rachel N. Grisham Clovis Oncology, Mateon Context Therapeutics (Inst) EMD Serono Therapeutics, Regeneron
Helen Mackay AstraZeneca Amanda Nickles Ethicon Fader Debra L. Foundation Medicine, ArQule (Inst), AstraZeneca (Inst), Agenus, Karyopharm Richardson Genentech/Roche, Ipsen, Deciphera (Inst), Genentech (Inst), Therapeutics, Merck, Tesaro Innovent Biologics (Inst), Lycera Roche, Tesaro (Inst), Merck (Inst), Roche (Inst), Syros Pharmaceuticals (Inst), Tesaro (Inst) Head and Neck Cancer Maura L. Gillison BioMimetix, Bristol-Myers Bristol-Myers Squibb (Inst), Genocea Squibb, EMD Serono, Biosciences (Inst) Genocea Biosciences, Merck, Roche
Faye M. Johnson Methodist Hospital PIQUR, Trovagene
Alexander Lin Galera Elekta Therapeutics, Ion Beam Applications
Jochen H. Lorch Bayer, Eisai, Genentech Bayer (Inst), Bristol-Myers Squibb (Inst), Millennium (Inst), Novartis (Inst)
Steven F. Powell Bristol-Myers Squibb (Inst) Bristol-Myers Squibb (Inst), Genentech/Roche (Inst), Incyte (Inst), Merck Sharp & Dohme (Inst), Novartis (Inst), Pfizer (Inst), Vyriad (Inst)
Ravindra Uppaluri Merck Merck
Health Services Research and Quality Improvement Tareq Al Baghdadi Array BioPharma, Cardinal Health, Bristol-Myers Squibb, Bristol-Myers Squibb, AstraZeneca, Biogin, Medscape Celgene, HERON Cardinal Health, Bristol-Myers Celgene, HERON Squibb, Celgene, Epizyme, HERON, Merck, Portola Pharmaceuticals, Seattle Genetics, Spectrum Pharmaceuticals, Sunesis Pharmaceuticals, TRACON Pharma Aditya Bardia bioTheranostics, bioTheranostics Genentech, Genentech/Roche (Inst), Immunomedics (Inst), Immunomedics, Innocrin Pharma (Inst), Merck, Novartis (Inst), Novartis, Pfizer (Inst), Pfizer, Puma Biotechnology, Radius Health (Inst), Radius Pharma, Sanofi, Spectrum Pharmaceuticals
Gabriel A. Brooks CareCentrix Boston Biomedical (Inst) Merck Sharp & Dohme
Stewart B. Fleishman Rachel A. Eisai (Inst), Puma Biotechnology Freedman (Inst) Faithlore P. bioTheranostics, Oasis Gardner 360 Jimmy Ruiz AstraZeneca AstraZeneca, AstraZeneca, BeyondSpring AstraZeneca, Genentech Pharmaceuticals, Roche Genentech/Roche Erica T. Warner Hematologic Malignancies-Leukemia, MDS, and Allotransplant Caitlin Costello Celgene, Takeda Celgene (Inst), Janssen (Inst), Takeda Takeda (Inst) Leslie R. Ellis Alexion Alexion Pharmaceuticals Alexion Alexion Pharmaceuticals Pharmaceuticals Pharmaceuticals, ASH
Elihu Estey Mehdi Hamadani Celgene ADC Therapeutics, AstraZeneca, Celgene, Astellas Pharma, Genzyme, Otsuka Cellerant Therapeutics, Genzyme US, Spectrum Pharmaceuticals, Incyte Coporation, Takeda Janssen Research & Development, MedImmune, Pharmacyclics, Puma Biotechnology (I)
Milos Miljkovic Hematologic Malignancies-Lymphoma and CLL Nancy L. Bartlett ADC Therapeutics, Pfizer, Affimed Therapeutics (Inst), Bristol- Seattle Genetics Myers Squibb (Inst), Celgene (Inst), Forty Seven (Inst), Genentech (Inst), Gilead Sciences (Inst), Immune Design (Inst), Janssen (Inst), Kite Pharma (Inst), Merck (Inst), Millennium (Inst), Pharmacyclics (Inst), Seattle Genetics (Inst)
Matthew S. Davids Research to Abbvie, Acerta Pharma, Acerta Pharma (Inst), Bristol-Myers TG Therapeutics Practice Adaptive Biotechnologies, Squibb (Inst), Genentech (Inst), MEI AstraZeneca, Celgene, Pharma (Inst), Pharmacyclics (Inst), Genentech, Gilead Surface Oncology (Inst), TG Sciences, Janssen, MEI Therapeutics (Inst), Verastem (Inst) Pharma, Pharmacyclics, Roche, Syros Pharmaceuticals, TG Therapeutics, Verastem
Mary Jo Lechowicz Kyowa Hakko Kirin Kyowa Hakko Kirin John P. Leonard ADC Therapeutics, Alliance for Clinical Trials in Oncology BeiGene AstraZeneca, Bayer, (Inst), Celgene (Inst), National Cancer Beigene, Biotest, Bristol- Institute (Inst), Pfizer (Inst), Takeda Myers Squibb, Celgene, (Inst) Epizyme, Genentech/Roche, Gilead Sciences, Karyopharm Therapeutics, MEI Pharma, Merck, Morphosys, Nordic Nanovector, Novartis, Pfizer, Sandoz, Sunesis Pharmaceuticals, Sutter Medical Group, United Therapeutics
Leslie Popplewell Spectrum Roche Genentech, Janssen Research & Spectrum Pharmaceuticals Development, Millennium, Novartis, Pharmaceuticals Pfizer, Pharmacyclics Hematologic Malignancies-Plasma Cell Dyscrasia Jesus G. Berdeja Bristol-Myers Squibb Abbvie (Inst), Amgen (Inst), Bluebird (Inst), Celgene (Inst), Bio (Inst), Bristol-Myers Squibb (Inst), Crispr Therapeutics (Inst), Celgene (Inst), Genentech/Roche Karyopharm Therapeutics (Inst), Glenmark (Inst), Janssen (Inst), (Inst), Kite Pharma (Inst), Novartis (Inst), Poseida Therapeutics SERVIER (Inst), Takeda (Inst), Sanofi (Inst), Takeda (Inst), (Inst) Teva (Inst)
Suzanne Lentzsch Caelum Biosciences Abbvie, Bayer Schering Clinical Care Karyopharm, Sanofi Patent 11-1F4 mAb for use in Janssen Sorrento Pharma, Bristol-Myers Options/NCCN AL Amyloidosis Squibb, Caelum Biosciences, Janssen, Novartis, Proclara, Takeda Sham Mailankody Physician Education Janssen Oncology (Inst), Juno Resource, Weber Therapeutics (Inst), Takeda (Inst) Shandwick
Philip L. McCarthy Bristol-Myers Bristol-Myers Squibb, Celgene (Inst) Squibb, Celgene, Celgene, Janssen, Janssen, Karyopharm Karyopharm Therapeutics, Magenta, Therapeutics, Sanofi, The Binding Site Sanofi, The Binding Site Noopur S. Raje Amgen, Bristol-Myers AstraZeneca (Inst) Squibb, Celgene, Janssen Oncology, Merck, Novartis, Takeda
Saad Z. Usmani Celgene, Amgen, Janssen Celgene, Takeda, Celgene, Array BioPharma, Janssen Oncology, Seattle Amgen, Janssen Oncology, Pharmacyclics, Sanofi, Genetics, Takeda, Oncology Bristol-Myers Squibb, Amgen, Seattle GlaxoSmithKline, Genetics Karyopharm Therapeutics, Abbvie, SkylineDX
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Jamie E. Chaft AstraZeneca/ AstraZeneca/MedImmune (Inst), MedImmune, Bristol- Bristol-Myers Squibb (Inst), Myers Squibb, Genentech/Roche (Inst), Merck (Inst) Genentech/Roche, Merck
Maximilian Diehn CiberMed AstraZeneca, BioNTech, Varian Medical Systems Patent filings on ctDNA AstraZeneca, Roche, Roche detection assigned to Varian Medical Systems Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Anna F. Farago Clinical Care Abbvie, Abbvie (Inst), Amgen (Inst), Abbvie, Options, Abbvie/Stemcentrx, AstraZeneca (Inst), Bayer (Inst), Abbvie/Stemcentrx, DAVAOncology, AstraZeneca, Bayer, Bristol-Myers Squibb (Inst), AstraZeneca, Bayer, Medical Learning Boehringer Ingelheim, Genentech/Roche (Inst), Ignyta (Inst), Boehringer Ingelheim, Institute, Medscape Genentech/Roche, Loxo, Loxo (Inst), Merck (Inst), Novartis DAVAOncology, PharmaMar (Inst), PharmaMar (Inst) Genentech/Roche, Loxo, PharmaMar Ryan D. Gentzler AstraZeneca Bristol-Myers Squibb (Inst), Helsinn Helsinn Therapeutics Therapeutics (Inst), Merck (Inst), Takeda (Inst) Jhanelle E. Gray Array BioPharma, AstraZeneca, Celgene, Array BioPharma (Inst), AstraZeneca AstraZeneca/ AstraZeneca, Takeda (Inst), Boehringer Ingelheim (Inst), MedImmune, Boehringer Boehringer Bristol-Myers Squibb (Inst), Epic Ingelheim, Celgene, Lilly, Ingelheim, Bristol Sciences (Inst), Genentech/Roche Takeda Meyers Squibb, (Inst), Merck (Inst), Novartis (Inst), Celgene, Lilly, Trovagene (Inst) Genentech, Merck, Takeda Jay M. Lee AstraZeneca, Merck Genentech/Roche Genentech/Roche, Regeneron Jyoti D. Patel Abbvie, AstraZeneca, Takeda Science Foundation Jared Weiss Nektar Pfizer Abbvie, AstraZeneca, Amgen (Inst), Celgene, EMD Serono, AstraZeneca/MedImmune (Inst), G1 Therapeutics, Carefusion (Inst), Celgene (Inst), G1 Genentech, Inivata, Therapeutics (Inst), Merck (Inst), Jounce Therapeutics, Novartis (Inst), Pfizer (Inst) Nanobiotix, Rakuten
Lung Cancer - Non-small Cell Metastatic Mark M. Awad Abbvie, ARIAD, AstraZeneca (Inst), Bristol-Myers AstraZeneca/ Squibb (Inst), Bristol-Myers Squibb, MedImmune, Blueprint Genentech/Roche (Inst), Lilly (Inst) Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis Oncology, Foundation Medicine, Genentech, Maverick Therapeutics, Merck, Nektar, Novartis, Pfizer, Syndax Hossein Borghaei SonnetBio, RGenix Axiom Abbvie, AstraZeneca, Bristol-Myers Squibb (Inst), Celgene Bristol-Myers Squibb, Takeda, University Biotechnologies, BioNTech, Boehringer (Inst), Lilly (Inst), Merck (Inst), Celgene, Clovis of Pennsylvania Bristol-Myers Ingelheim, Bristol-Myers Millennium (Inst) Oncology, Genentech, Squibb, Celgene Squibb, Cantargia, Lilly, Merck, Novartis Celgene, EMD Serono, Genentech, Genmab, Lilly, Merck, Novartis, Pfizer, PharmaMar, Regeneron, Takeda, Trovagene
Robert C. Doebele Rain Therapeutics AstraZeneca, Bayer, Ignyta (Inst) Licensing Fees from Abbott Ignyta; Rain GreenPeptide, Ignyta, Molecular for Patent Therapeutics; OncoMed, Rain PCT/US2013/057495; Roche/Genentech Therapeutics, Licensing fees from Ignyta for Roche/Genentech, biologic materials (Inst); Takeda Licensing fees for biologic materials from Genentech (Inst); Licensing fees for patent from Rain Therapeutics; Licensing fees for biologic materials from Foundation Medicine (Inst); Licensing fees for biologic materials from Black Diamond (Inst)
Marina C. AstraZeneca/ AstraZeneca, Bristol- AstraZeneca, Bristol- AstraZeneca (Inst), AstraZeneca, Pfizer, Garassino MedImmune, Bristol- Myers Squibb, MSD, Myers Squibb, AstraZeneca/MedImmune (Inst), Roche Myers Squibb, Novartis, Roche, Sanofi- Celgene, Incyte, MSD Blueprint Medicines, Bristol-Myers GlaxoSmithKline, Aventis, Takeda, Tiziana Oncology, Roche, Squibb (Inst), Lilly (Inst), MSD Oncology, Life Sciences Takeda GlaxoSmithKline (Inst), Incyte (Inst), Roche, Takeda Merck (Inst), MSD (Inst), Novartis (Inst), Pfizer (Inst), Roche/Genentech (Inst), Spectrum Pharmaceuticals (Inst), Takeda (Inst)
Christine L. Hann Abbvie, GlaxoSmithKline (Inst), Abbvie (Inst), AstraZeneca, Genentech/Roche, Bristol- Bristol-Myers Squibb (Inst), Merrimack Abbvie/Stemcentrx, Myers Squibb, Ascentage (Inst), Amgen Bristol-Myers Squibb Pharma Benjamin P. Levy AstraZeneca, Celgene, Genentech/Roche, Guardant Health, Lilly, Merck, Pfizer, Takeda Christine M. Lovly ARIAD, ARIAD, AstraZeneca, Astra Zeneca (Inst), Novartis, Xcovery ARIAD, Cepheid, AstraZeneca, BluePrint Medicine, Foundation Medicine, BluePrint Medicine, Cepheid, Foundation Genoptix, Novartis, Cepheid, Medicine, Genoptix, Pfizer, Sequenom, Foundation Novartis, Pfizer, Takeda Takeda Medicine, Genoptix, Novartis, Pfizer, Sequenom, Takeda
Rathi N. Pillai AstraZeneca, Natera Bristol-Myers Squibb Clovis Oncology, Genentech/Roche, Novartis, Takeda Melanoma/Skin Cancers Douglas B. Array Biopharma, Bristol- Bristol-Myers Squibb, Incyte Intellectual property and Genentech Johnson Myers Squibb, Incyte, patents pending surrounding Merck, Novartis use of MHC-II and response to immune therapy
Jason J. Luke Actym Therapeutics, 7 Hills Pharma, Abbvie, Abbvie (Inst), Array BioPharma, Serial #15/612,657 (Cancer Akrevia, Amgen, Array Alphamab Oncology, Actym Therapeutics, Boston Biomedical (Inst), Bristol- Immunotherapy); Serial BioPharma, Mavu Aduro Biotech, Akrevia, Myers Squibb (Inst), Celldex (Inst), #PCT/US18/36052 AstraZeneca/ Pharmaceutical, Alphamab Oncology, Checkmate Pharmaceuticals, (Microbiome Biomarkers for MedImmune, Benevir, Pyxis, Tempest Amgen, Array BioPharma, Compugen (Inst), Corvus Anti-PD-1/PD-L1 Bristol-Myers Squibb, Therapeutics Astellas Pharma, Pharmaceuticals (Inst), Delcath Responsiveness: Diagnostic, Castle Biosciences, AstraZeneca/ Systems (Inst), Evelo Therapeutics, Prognostic and Therapeutic Checkmate MedImmune, Bayer, Five Prime Therapeutics (Inst), FLX Uses Thereof) Pharmaceuticals, EMD Benevir, Bristol-Myers Bio, Genentech/Roche (Inst), Serono, Gilead Squibb, Compugen, EMD Immunocore (Inst), Incyte (Inst), Sciences, IDEAYA Serono, IDEAYA Macrogenics (Inst), MedImmune Biosciences, Biosciences, Immunocore, (Inst), Merck (Inst), Novartis (Inst), Immunocore, Janssen, Incyte, Janssen, Jounce Palleon Pharmaceuticals, Jounce Therapeutics, Therapeutics, Leap Pharmacyclics (Inst), Tesaro (Inst), Merck, Mersana, Therapeutics, Mavu Xencor (Inst) Novartis, Reflexion Pharmaceutical, Merck, Medical Mersana, Novartis, Reflexion Medical, Spring Bank, Tempest Therapeutics, TTC Oncology, Vividion
Janice M. Mehnert EMD Serono, Amgen, Array BioPharma, Amgen (Inst), AstraZeneca (Inst), Array BioPharma, Bristol- Amgen, Array Pfizer/EMD Serono Boehringer Ingelheim, Bristol Myers Squibb (Inst), Myers Squibb, EMD BioPharma, Merck Sharp & Dohme Immunocore (Inst), Incyte (Inst), Serono, Merck Sharp & Boehringer Macrogenics (Inst), Merck (Inst), Dohme Ingelheim, EMD Novartis (Inst), Polynoma (Inst), Serono, Merck Sanofi (Inst) April K. Salama Array BioPharma, Bristol-Myers Squibb Abbvie (I), Bristol-Myers Squibb (Inst), BioCryst, Merck Celldex (Inst), Dynavax (Inst), Genentech (Inst), Immunocore (Inst), Merck (Inst), Reata Pharmaceuticals (Inst) Pediatric Oncology Jacqueline N. Casillas Steven G. DuBois Loxo Loxo BMS (Inst), Curis (Inst), Lilly (Inst), Loxo, Roche/Genentech Loxo (Inst), Merck (Inst), Millennium (Inst), Novartis (Inst), Roche/Genentech (Inst) Shannon L. Maude Kite Pharma, Novartis
Emily K. Slotkin Lilly (Inst) Lilly Professional Development and Education Advances Annie P. Im Incyte Gregory P. BioMed Valley Abbvie (Inst), Merck (Inst), Takeda Kalemkerian Discoveries (I), Boston (Inst) Biomedical (I), Molecular Templates (I), Skyline Biosciences (I), Takeda (I), Unum Therapeutics (I)
Pamela L. Kunz Guardant Health Advanced Accelerator Advanced Accelerator Applications Applications, Ipsen, (Inst), Brahams (Inst), Genentech Lexicon, Novartis (Inst), Ipsen (Inst), Lexicon (Inst), Xencor (Inst) W. Robert Lee Augmenix UpToDate Editor Adriana K. Malone
Sarcoma Thierry Alcindor Amgen, Astellas Pharma, CytRx Corporation (Inst), Eisai (Inst), Bristol-Myers Squibb, EMD Serono (Inst), Epizyme (Inst), Eisai, Immune Design, Karyopharm Therapeutics (Inst), Lilly Lilly, Novartis, Pfizer/EMD (Inst), Springworks (Inst) Serono, Shire, Taiho Pharmaceutical
Katherine A. Bayer Amgen (Inst), Pfizer (Inst) Bayer Janeway Shiraj Sen Daiichi Sankyo (Inst) BioAtla (Inst), Exelixis (Inst), Jacobio (Inst), Loxo (Inst) Sam S. Yoon Symptoms and Survivorship Shail Maingi Merck (I) Merck (I) Merck (Inst), Tactile Medical (Inst) Christine Miaskowski Shoshana M. Cantel Medical, Rosenberg Edwards Lifesciences Mina S. Sedrak Novartis (Inst), Seattle Genetics (Inst)
Cardinale B. Smith Teva Teva Teva
Martin R. Stockler Amgen (Inst), Astellas Pharma (Inst), Medivation/Pfizer AstraZeneca (Inst), Bayer (Inst), Bionomics (Inst), Bristol-Myers Squibb (Inst), Celgene (Inst), Medivation (Inst), Merck Sharp & Dohme (Inst), Pfizer (Inst), Roche (Inst), Sanofi (Inst), Tilray (Inst)
Maxwell T. Vergo Suparna B. Wedam